デフォルト表紙
市場調査レポート
商品コード
990516

にきび薬市場規模調査:にきび薬タイプ別、薬クラス別、薬タイプ別、投与経路別-2026年までの世界予測-COVID-19の累積的影響

Acne Drugs Market Research Report by Acne Type, by Drug Class, by Drug Type, by Route of Administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
にきび薬市場規模調査:にきび薬タイプ別、薬クラス別、薬タイプ別、投与経路別-2026年までの世界予測-COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のにきび薬の市場規模は、2020年の51億2397万米ドル規模から2025年末までに71億4637万米ドル規模に成長すると予想されています。

市場セグメンテーションとカバレッジ

当調査は、にきび薬を分類して収益を予測し、次の各サブマーケットの動向を分析します。

にきび別では、にきび薬市場は、面皰、嚢胞、炎症、および術後/創傷にわたって調査されました。

薬クラス別では、にきび薬市場は抗生物質、併用薬、ホルモン剤、およびレチノイドにわたって調査されました。

薬タイプ別では、にきび薬市場はOTC薬と処方薬にわたって調査されました。

投与経路別では、にきび薬市場は注射、経口、および局所にわたって調査されました。

地域別では、にきび薬市場は南北アメリカ、アジア太平洋、欧州、中東・アフリカで調査されました。

COVID-19の累積的影響

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮したCOVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

レポートは、次の指針に関する洞察を提供します。

1.市場浸透:主要なプレーヤーにより提供される市場に関する包括的な情報

2.市場開発:収益性の高い新興市場に関する詳細な情報と市場分析

3.市場の多様化:新製品の発売、未開発の地域、最近の開発、および投資に関する詳細情報

4.競争力のある評価とインテリジェンス:主要企業の市場シェア、戦略、製品、製造能力の徹底的な評価

5.製品開発とイノベーション:将来のテクノロジー、R&D活動、および新製品開発に関するインテリジェントな洞察

レポートは、次のような質問に答えます。

1.当世界市場の規模と予測はどのようなものですか?

2.予測期間中に市場を形成するCOVID-19の阻害要因と影響は何ですか?

3.予測期間中に投資する製品、セグメント、アプリケーション、領域はどれですか?

4.市場における機会のコンペティティブ・ストラテジック・ウィンドウは何ですか?

5.市場の技術動向と規制の枠組みは何ですか?

6.市場に参入するのに適していると考えられるモードと戦略的動きは何ですか?

当レポートでは、にきび薬市場を調査し、市場概要、市場の成長要因および阻害要因の分析、にきび薬タイプ別、薬クラス別、薬タイプ別、投与経路別、地域別の市場規模の推移と予測、COVID-19の累積的影響、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 薬剤タイプ別の見通し
  • 投与経路別の見通し
  • 医薬品クラス別の見通し
  • にきびタイプ別の見通し
  • 地域別の見通し
  • 競合他社別の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 にきび薬タイプ別の世界のにきび薬市場

  • イントロダクション
  • コメドナル
  • 嚢胞
  • 炎症性
  • 術後/創傷

第7章 薬のクラス別の世界のにきび薬市場

  • イントロダクション
  • 抗生物質
  • 併用薬
  • ホルモン剤
  • レチノイド

第8章 薬タイプ別の世界のにきび薬市場

  • イントロダクション
  • OTC薬
  • 処方薬

第9章 投与経路別の世界のにきび薬市場

  • イントロダクション
  • 注射
  • 口腔摂取
  • 局所

第10章 南北アメリカのにきび薬市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のにきび薬市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第12章 欧州、中東・アフリカのにきび薬市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第14章 企業のユーザビリティプロファイル

  • AbbVie Inc.
  • Almirall, S.A.
  • AndroScience Corporation
  • Anterios Inc
  • Bausch Health Companies Inc.
  • Bayer AG
  • BioPharmX, Inc
  • Cipher Pharmaceuticals Inc.
  • Daiichi Sankyo Company, Ltd
  • F. Hoffmann-La Roche AG
  • Foamix Pharmaceuticals Ltd.
  • Galderma S.A.
  • Guthy-Renker LLC
  • Johnson & Johnson Services, Inc
  • Mayne Pharma Group Limited
  • Medicis Pharmaceutical Corporation
  • Mylan N.V
  • Oculus Innovative Sciences
  • Pfizer Inc.
  • Ranbaxy Laboratories Limited
  • Skinvisible Pharmaceuticals
  • Stiefel Laboratories, Inc
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd
  • Valeant Pharmaceutical International Inc

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACNE DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ACNE DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL ACNE DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2026
  • FIGURE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2026
  • FIGURE 23. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (%)
  • FIGURE 32. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2026
  • FIGURE 34. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
  • FIGURE 39. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
  • FIGURE 41. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
  • FIGURE 44. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, 2018-2026 (USD MILLION)
  • FIGURE 46. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 48. AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 50. ARGENTINA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. BRAZIL ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. CANADA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. MEXICO ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. UNITED STATES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. CALIFORNIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. FLORIDA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. ILLINOIS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. NEW YORK ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. OHIO ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. TEXAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 63. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 65. CHINA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. INDIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. INDONESIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. JAPAN ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. MALAYSIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. PHILIPPINES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. THAILAND ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 74. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 76. FRANCE ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. GERMANY ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. ITALY ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. NETHERLANDS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. QATAR ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. RUSSIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. SPAIN ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 87. GLOBAL ACNE DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 88. GLOBAL ACNE DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 89. GLOBAL ACNE DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 90. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACNE DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ACNE DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. AMERICAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ARGENTINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ARGENTINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. BRAZIL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. BRAZIL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CANADA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CANADA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CANADA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CANADA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. MEXICO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. MEXICO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. UNITED STATES ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED STATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. UNITED STATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CALIFORNIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CALIFORNIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CALIFORNIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CALIFORNIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. FLORIDA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. FLORIDA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. FLORIDA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. FLORIDA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ILLINOIS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ILLINOIS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ILLINOIS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ILLINOIS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. NEW YORK ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. NEW YORK ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. NEW YORK ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. NEW YORK ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. OHIO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. OHIO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. OHIO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. OHIO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. PENNSYLVANIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. TEXAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. TEXAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. TEXAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. TEXAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. CHINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. CHINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. CHINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. CHINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. INDIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. INDIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. INDIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. INDIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. INDONESIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. INDONESIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. JAPAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. JAPAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. MALAYSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. MALAYSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. THAILAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. THAILAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. FRANCE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. FRANCE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. GERMANY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. GERMANY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. ITALY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. ITALY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. ITALY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. ITALY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. QATAR ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. QATAR ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. QATAR ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. QATAR ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. RUSSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. RUSSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. SPAIN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SPAIN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. GLOBAL ACNE DRUGS MARKET: SCORES
  • TABLE 161. GLOBAL ACNE DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 162. GLOBAL ACNE DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 163. GLOBAL ACNE DRUGS MARKET: RANKING
  • TABLE 164. GLOBAL ACNE DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 165. GLOBAL ACNE DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 166. GLOBAL ACNE DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 167. GLOBAL ACNE DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 168. GLOBAL ACNE DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 169. GLOBAL ACNE DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 170. GLOBAL ACNE DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 171. GLOBAL ACNE DRUGS MARKET: LICENSE & PRICING
  • TABLE 172. GLOBAL ACNE DRUGS MARKET: CONTACT DETAILS
目次
Product Code: MRR-434CCDA051B6

The Global Acne Drugs Market size was estimated at USD 5,123.97 Million in 2020 and expected to reach USD 5,502.11 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.71% to reach USD 8,004.64 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Acne Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Acne Type, the Acne Drugs Market was studied across Comedonal, Cystic, Inflammatory, and Postsurgical/Wound.

Based on Drug Class, the Acne Drugs Market was studied across Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids.

Based on Drug Type, the Acne Drugs Market was studied across OTC Drugs and Prescription Drugs.

Based on Route of Administration, the Acne Drugs Market was studied across Injectable, Oral, and Topical.

Based on Geography, the Acne Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acne Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Acne Drugs Market, including AbbVie Inc., Almirall, S.A., AndroScience Corporation, Anterios Inc, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc, Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd, F. Hoffmann-La Roche AG, Foamix Pharmaceuticals Ltd., Galderma S.A., Guthy-Renker LLC, Johnson & Johnson Services, Inc, Mayne Pharma Group Limited, Medicis Pharmaceutical Corporation, Mylan N.V, Oculus Innovative Sciences, Pfizer Inc., Ranbaxy Laboratories Limited, Skinvisible Pharmaceuticals, Stiefel Laboratories, Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, and Valeant Pharmaceutical International Inc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Acne Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acne Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acne Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Acne Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Acne Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Acne Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Acne Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Drug Type Outlook
  • 3.4. Route of Administration Outlook
  • 3.5. Drug Class Outlook
  • 3.6. Acne Type Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive occurrence of skin-related diseases in individuals such as acne rosacea
      • 5.1.1.2. Burgeoning awareness among people about the perks of using skin care products
      • 5.1.1.3. Increasing presence on potential online retail platforms coupled with available disposable income
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of numerous alternatives for skin care drugs such as Ayurveda
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising proclivity among consumers for cosmetics made of natural ingredients
      • 5.1.3.2. Emerging demand for combination therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and complicated process in the approval of cosmetic drugs
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Acne Drugs Market, by Acne Type

  • 6.1. Introduction
  • 6.2. Comedonal
  • 6.3. Cystic
  • 6.4. Inflammatory
  • 6.5. Postsurgical/Wound

7. Acne Drugs Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Combination Drugs
  • 7.4. Hormonal Agents
  • 7.5. Retinoids

8. Acne Drugs Market, by Drug Type

  • 8.1. Introduction
  • 8.2. OTC Drugs
  • 8.3. Prescription Drugs

9. Acne Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Americas Acne Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Acne Drugs Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Acne Drugs Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. AbbVie Inc.
  • 14.2. Almirall, S.A.
  • 14.3. AndroScience Corporation
  • 14.4. Anterios Inc
  • 14.5. Bausch Health Companies Inc.
  • 14.6. Bayer AG
  • 14.7. BioPharmX, Inc
  • 14.8. Cipher Pharmaceuticals Inc.
  • 14.9. Daiichi Sankyo Company, Ltd
  • 14.10. F. Hoffmann-La Roche AG
  • 14.11. Foamix Pharmaceuticals Ltd.
  • 14.12. Galderma S.A.
  • 14.13. Guthy-Renker LLC
  • 14.14. Johnson & Johnson Services, Inc
  • 14.15. Mayne Pharma Group Limited
  • 14.16. Medicis Pharmaceutical Corporation
  • 14.17. Mylan N.V
  • 14.18. Oculus Innovative Sciences
  • 14.19. Pfizer Inc.
  • 14.20. Ranbaxy Laboratories Limited
  • 14.21. Skinvisible Pharmaceuticals
  • 14.22. Stiefel Laboratories, Inc
  • 14.23. Sun Pharmaceutical Industries Limited
  • 14.24. Teva Pharmaceutical Industries Ltd
  • 14.25. Valeant Pharmaceutical International Inc

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details